Tài liệu, văn bản bạn tìm kiếm
Risk groups, Male breast cancer, Chemoradiation resistance pathways, Negative disease outcome, Hematopoietic malignancies, Sophisticated genetic mutations, PKCε downregulation, Epigenetic dysregulation, Aberrant crypt foci, Second primary tumours, Sialyl T antigen, Nasopharyngeal EBV load, Multicenter phase II study, Thomsen-Friedenreich antigen, Nasopharyngeal EBV reactivation, Tumorassociated O-linked carbohydrates, Radiological monitoring, Upper tract, Modified RECIST criteria, Ureteroscopic treatment, Inter-observer variability, Widespread metastasis, Especially meningeal metastases, Transient receptor potential canonical C5, Radiotherapy related skin toxicity, Screen-film mammography, Interval cancers, Programme sensitivity, Programme specificity, Autophagy sensitizes cancer cells, Small cell lung cancers, Photofrin-based photodynamic therapy, Several pediatric tumors, Pro-survival mechanism, Alveolar rhabdomyosarcomas, Risk assessment tool, Stem-like cancer cells, Akt signaling, Whole cell patch clamp, Ca2+ channel, Treatment preferences, Familial cancer, Potential overdiagnosis, Attenuation-artefact, Compound A, Potent anti-cancer drug, Health related burden, Total economic, Improved outcome, Platelet-derived growth factor receptor alpha polypeptide, Esophageal sarcomatoid carcinoma, Innate lymphoid cells, Influence treatment decisions, Judge biological mechanisms, Behavioural medicine, Promote earlier diagnosis, Epithelial growth factor receptor, Tissue biopsy methods, Alcohol-related disorders, Cancer outcome, Population-based mammography, A549 cells, Ovarian metastases, Bilateral annexiectomy, Common bile duct, Periampullary adenocarcinoma, Community pharmacists, Possible cancer-related symptoms, Smartphone applications, M-health interventions, Leucine-rich alpha-2-glycoprotein-1, Informal cancer carers, Recruitment rates, Routine mammography, Breast screening regularly, Predominantly perceived barriers, Timely diagnosis, Delay in diagnosis, Breast cancer knowledge, Helicase-like Transcription Factor, Gene hypermethylation, Women’s health care system, Time after Radiotherapy, Pain symptoms during, CNKSR2 protein stability, HECT E3 ubiquitin ligase Smurf2, Multiple receptor tyrosine kinase pathways, Orthotopic liver transplantation, Treated metastases control, Sync-oligometastases, Psychosocial oncology, Lifestyle behaviours, General wellbeing, Metastatic chemorefractory disease, Sychronous metastases, Growth differentiation factor 15, Debulking surgery, Capture-base sequencing, Blood tumor mutational burden, Fine needle cytology, Scar recurrence, Toluidine blue, COX-catalyzed DGLA peroxidation, delta-5-desaturase, D5D knockdown MDA-MB 231, Breast cancer growth, Transcription-induced chimera, Gene fusion, Tumor-promoting properties, Metastatic atypical bronchial carcinoid, T4 tumor, HER2 mutation, Investigational arm, Diamond-Blackfan anemia, 5q- syndrome, Anthocyanidin monomers, HER-2 positive breast cancer, Reproductive factors, Hormonal pathways, 5-gene score, G1-G6 subgroups, Prognostically informative, Tissue inhibitor of metalloproteinases-1, Androgenic alopecia, The Warburg effect, Hepatic gluconeogenesis, Stage IV, Zinc ionophore, NF-κB signalling pathway, Normal CEA, Barcelona clinical liver Cancer, Anti-tumor immune response, Immune-related adverse, EGFR testing, T-cell lymphoblastic lymphoma, Anti-PD-1 immunotherapy, Hospital referral region, CDKN1C-E2F1-TP53 deregulation, Billing code, Moroccan population, Deregulation of miRNAs, Acantholytic squamous cell carcinoma, Lymphogenous metastasis, Route to diagnosis, Hospital costs, Organotypic culture, Overwhelming mortality, Anti-EGFR monoclonal antibody, Human regenerating islet-derived gene 4, Histologically classified oligodendrogliomas, Molecular subgroup, Lethal gynecological malignancy, C3H mice, Reduced representation bisulfite sequencing, Metastatic lung adenocarcinoma, CEA-stimulated macrophages, Post-operative radiotherapy, Asbestos-related diseases, Dynamic change, Time to diagnosis, Extremity osteosarcoma, Spindle cell carcinoma, Excisional biopsy, Fineneedle aspiration cytology, Diagnostic role, Vimentin protein immunoassay, MYC overexpression, Autophagy and apoptosis, Drug tolerance, Magnolia officinalis, Frequently hyperactivated, Solitary kidney, Solitary-functioning kidney versus, Klatskin tumor, Multidomain transmembrane, BRCA2 mutations characterized, Clonogenic capacity, Pre-diabetes appears, Cathepsin K, Cysteine cathepsins, Ongoing healthcare reform, Benign obstetrician, Fibroglandular breast tissue, Neoadjuvant degarelix, Apalutamide followed, Placebocontrolled trial, Tumour genomic profiling, Germline sequencing, Oxygenated solvents, Localized gastric cancer, Cancer bioinformatics, In silico modeling, Alternative animal experimentation, Investigator questionnaire, Peptidyl arginine deiminase, BB-cl-Amidine, Thoracic malignant tumor, Locally advanced disease, Tumor neoantigens, Population-level distribution, Putative immunogenicity, Cancer neoepitopes, Revision rate, Recurrent gastric cancer, Oral fluoropyrimidine, B-cell lymphoma 2, DNA fragmentation factor 40, DNA fragmentation factor 45, Endometrial cancers, Activated CD4+, Adjuvant platinum-based chemotherapy, Histone H3, Remarkable antitumor activities, Potential antitumor drug, Bortezomib prevents cytarabine, NF-κB activity, High-dose cytarabine, Small renal tumor remains, Zymogen granule protein 16, Pathogenic mutations, Mesothelioma stem cell, RN5-EOS-Puro2 cells, Cancer cell repopulation, Recombinant TRAIL, Caspase-dependent, Various proteasome inhibitors, ZBP-89, Kruppel family, Comparative transcriptome analyses, Zinc binding protein 89, Specificity protein, Medical expenses, Per capita disposable, BCMO1 polymorphisms, Germline genomic sequencing, Synchronous cancer, Chemotherapy scheme modifications, Melanoma brain metastasis, Tumor regression, Malignant epithelioid mesothelioma, Standard chemotherapy, Health economic modeling, Adenoma detection rate, Proximal serrated polyp detection rate, Subungual glomus tumor, Embryonic Liver Fodrin, Finger infection, Rare benign neoplasm, Tissue heterogeneity, Non-completion, Survival rates, Fast track endoscopy, Dose reduction, Metastatic colon cancer, Bone morphogenetic protein 1, Cell mobility, Anti-HER2 therapy, Multi-gene signature, Common gene, Common function, Septin 7, Calcium-binding protein calretinin, Butyrate-responsive elements, Cancer-initiating cells, Major histocompatibility complex-I, Cytotoxic T lymphocytes, Transformed phenotype, Multiple variables, Colony-formation, Transcription factor PAX6, Anaplastic astrocytic glioma, Iodide uptake, Thyroid cells, Harrell’s C-index, Occult blood, Fecal immunochemical test, Female breast cancer, Aden Cancer Registry, Hodgkin diseases, Nonhodgkin lymphoma, E-selectin ligands, Sialyl-Lewis X, Sialyl-Lewis a, Extra-capsular growth, Low-risk prostate cancer, Computerized tomography, Adverse pathologic features, Nongestational choriocarcinoma, Spontaneous renal hemorrhage, Heterogeneous patient group, Dickkopf-1, Serrated polyps, Sessile serrated polyps, Cut value, Delay seeking healthcare, NF-κB and CREB, Advanced adenomas, ß-catenin pathway, Tumor area, Therapeutic genes, Laterally spreading tumour, Survival analysiss, Gene expression pattern analysis, High-grade intraepithelial neoplasia, Cancer diagnostics, Total number of lymph nodes, Lymph node ratio, Left colon cancer, Patient education websites, Testicular malignancy, Primary cardiac mycofibrosarcoma, Mean survival time, Breast cancer etiology, CD8+ tumor-infiltrating lymphocytes, Metabolomic profiles, T cell activation, Aerobic conditions, Normal cells metabolize energy, Pancreatic exocrine insufficiency, Unresectable pancreatic cancer, Pancreatic enzyme replacement therapy, Glutamate oxaloacetate transaminase 1, KRAS mutated cancer cells, Immunologically silent neoplasm, Integrin beta 3, TNC-associated integrin β3, Immunomodulatory agent, Establish pharmacokinetic parameters, Multinucleated phenotype, Nucleoporin Nup88, Nuclear pore complexes, Non-V600 BRAF mutation, PDX model, Orthotropic xenografts, Achieve increased therapeutic, Breast cancer model, Single selumetinib treatment, Ceramide transport, Ceramide synthesis, Ceramide distribution, Lipid transport, NF-κB upstream regulator, Lung adenocarcinoma cells, CRC tumors, Renal epithelioid angiomyolipoma, TSC2 mutation, Multi-level features extraction, mTOR pathway activation, Features fusion, Critical negative regulators, Features selection, H3K9 methyltransferase, T-lymphom invasion, Angiopoietin-like 4, Checkpoint blockade, Intracranial metastases, Immunotherapeutic treatment, Microwell-mesh platform, GSK-3 inhibitor, GSK-3 alpha, GSK-3 beta, NB cell lines, Base excision repair, AntiPD1 immunother, AntiMEK inhibitors, Histopathologic regression, Blood DNA, Epigenetic signature, Osteosarcoma patients according, Standard treatment, Unique clinical, Prognostic features according, HPV related cancer, Child health clinic, Multivariable logistic regressions model, Implantable biodegradable balloon, Rectal spacer, Ovarian cancer survival, Prediction of metastasis, Cancer antigen 125, Ca-125 marker, Mesenchymal-epithelial transition factor, Radiation resistance, Downstream pathways played, Autophagy-related, Minimal invasive surgery, Forkhead box protein C2, Aggressive phenotypes, Cystathionine-β-synthase, Cystathionine γ-lyase, ß-blocker, 3-Mercaptopyruvate sulfurtransfera, Repurposed drugs, NF-kappaB, IKK-epsilon, Non-canonical signaling, Dose Hypofractionation, Paired rectal cancer cell lines, Inflammatory response biomarker, Emerging inflammatory response biomarkers